Christopher Richard Anzalone

Insider Reports History

Location: Pasadena, CA
Signature: /s/Christopher Anzalone
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christopher Richard Anzalone:

Form 4 holding Chief Executive Officer, Director

ARROWHEAD PHARMACEUTICALS, INC.

Security class: Common Stock
Shares / value: 3,792,739
Estimated value: $251,799,942
Report date: 02 Jan 2026
Price: $66.39
Ownership: Direct

Form 4 holding Chief Executive Officer, Director

ARROWHEAD PHARMACEUTICALS, INC.

Security class: Stock Option (right to buy Common Stock)
Shares / value: 0
Estimated value
Report date: 29 Dec 2025
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Insider Reports Filed by Christopher Richard Anzalone

4 ARWR

ARROWHEAD PHARMACEUTICALS, INC.

Report period: 02 Jan 2026
Transactions: 2
Transaction value: -$871,703
Filing time: 05 Jan 2026, 21:39
Role: Chief Executive Officer, Director
Next action: Open filing details

4 ARWR

ARROWHEAD PHARMACEUTICALS, INC.

Report period: 29 Dec 2025
Transactions: 6
Transaction value: -$3,257,460
Filing time: 30 Dec 2025, 17:46
Role: Chief Executive Officer, Director
Next action: Open filing details

4 ARWR

ARROWHEAD PHARMACEUTICALS, INC.

Report period: 19 Dec 2025
Transactions: 5
Transaction value: -$1,771,022
Filing time: 23 Dec 2025, 18:01
Role: Chief Executive Officer, Director
Next action: Open filing details

4 ARWR

ARROWHEAD PHARMACEUTICALS, INC.

Report period: 17 Dec 2025
Transactions: 4
Transaction value: -$5,443,462
Filing time: 19 Dec 2025, 18:56
Role: Chief Executive Officer, Director
Next action: Open filing details

4 ARWR

ARROWHEAD PHARMACEUTICALS, INC.

Report period: 12 Dec 2025
Transactions: 13
Transaction value: -$12,348,802
Filing time: 16 Dec 2025, 13:14
Role: Chief Executive Officer, Director
Next action: Open filing details

4 ARWR

ARROWHEAD PHARMACEUTICALS, INC.

Report period: 09 Apr 2025
Transactions: 5
Transaction value: -$1,533,337
Filing time: 11 Apr 2025, 18:20
Role: Chief Executive Officer, Director
Next action: Open filing details

4 ARWR

ARROWHEAD PHARMACEUTICALS, INC.

Report period: 13 Mar 2025
Transactions: 2
Transaction value: -$774,975
Filing time: 17 Mar 2025, 17:45
Role: Chief Executive Officer, Director
Next action: Open filing details

4 ARWR

ARROWHEAD PHARMACEUTICALS, INC.

Report period: 03 Mar 2025
Transactions: 6
Transaction value: -$2,949,334
Filing time: 05 Mar 2025, 18:32
Role: Chief Executive Officer, Director
Next action: Open filing details

4 ARWR

ARROWHEAD PHARMACEUTICALS, INC.

Report period: 07 Feb 2025
Transactions: 1
Transaction value: +$191,955
Filing time: 10 Feb 2025, 18:23
Role: Chief Executive Officer, Director
Next action: Open filing details

4 ARWR

ARROWHEAD PHARMACEUTICALS, INC.

Report period: 02 Jan 2025
Transactions: 1
Transaction value: -$219,456
Filing time: 06 Jan 2025, 18:07
Role: Chief Executive Officer, Director
Next action: Open filing details

4 ARWR

ARROWHEAD PHARMACEUTICALS, INC.

Report period: 23 Dec 2024
Transactions: 1
Transaction value: -$246,109
Filing time: 23 Dec 2024, 16:39
Role: Chief Executive Officer, Director
Next action: Open filing details

4 ARWR

ARROWHEAD PHARMACEUTICALS, INC.

Report period: 18 Dec 2024
Transactions: 4
Transaction value: -$567,486
Filing time: 20 Dec 2024, 18:04
Role: Chief Executive Officer, Director
Next action: Open filing details

4 ARWR

ARROWHEAD PHARMACEUTICALS, INC.

Report period: 31 Jan 2024
Transactions: 4
Transaction value: -$1,023,984
Filing time: 02 Feb 2024, 17:25
Role: Chief Executive Officer, Director
Next action: Open filing details

4 ARWR

ARROWHEAD PHARMACEUTICALS, INC.

Report period: 02 Jan 2024
Transactions: 2
Transaction value: -$308,637
Filing time: 04 Jan 2024, 17:25
Role: Chief Executive Officer, Director
Next action: Open filing details

4 ARWR

ARROWHEAD PHARMACEUTICALS, INC.

Report period: 20 Dec 2023
Transactions: 1
Transaction value: -$342,480
Filing time: 22 Dec 2023, 17:04
Role: Chief Executive Officer, Director
Next action: Open filing details

4 ARWR

ARROWHEAD PHARMACEUTICALS, INC.

Report period: 25 Oct 2023
Transactions: 1
Transaction value: -$589,223
Filing time: 27 Oct 2023, 18:23
Role: Chief Executive Officer, Director
Next action: Open filing details

4 ARWR

ARROWHEAD PHARMACEUTICALS, INC.

Report period: 18 Sep 2023
Transactions: 4
Transaction value: -$1,349,886
Filing time: 20 Sep 2023, 18:10
Role: Chief Executive Officer, Director
Next action: Open filing details

4 ARWR

ARROWHEAD PHARMACEUTICALS, INC.

Report period: 03 May 2023
Transactions: 7
Transaction value: -$3,914,768
Filing time: 05 May 2023, 19:04
Role: Chief Executive Officer, Director
Next action: Open filing details

4 ARWR

ARROWHEAD PHARMACEUTICALS, INC.

Report period: 16 Dec 2022
Transactions: 2
Transaction value: $0
Filing time: 20 Dec 2022, 18:09
Role: Chief Executive Officer, Director
Next action: Open filing details

4 ARWR

ARROWHEAD PHARMACEUTICALS, INC.

Report period: 27 Sep 2022
Transactions: 2
Transaction value: -$1,250,679
Filing time: 29 Sep 2022, 17:15
Role: Chief Executive Officer, Director
Next action: Open filing details

4 ARWR

ARROWHEAD PHARMACEUTICALS, INC.

Report period: 08 Jul 2022
Transactions: 1
Transaction value: $0
Filing time: 12 Jul 2022, 19:39
Role: Chief Executive Officer, Director
Next action: Open filing details

4 ARWR

ARROWHEAD PHARMACEUTICALS, INC.

Report period: 07 Jul 2022
Transactions: 2
Transaction value: +$36,365
Filing time: 11 Jul 2022, 20:08
Role: Chief Executive Officer, Director
Next action: Open filing details

4 ARWR

ARROWHEAD PHARMACEUTICALS, INC.

Report period: 11 Feb 2022
Transactions: 6
Transaction value: -$6,839,111
Filing time: 14 Feb 2022, 07:54
Role: Chief Executive Officer, Director
Next action: Open filing details

4 ARWR

ARROWHEAD PHARMACEUTICALS, INC.

Report period: 07 Jan 2022
Transactions: 2
Transaction value: +$61,273
Filing time: 07 Jan 2022, 20:39
Role: Chief Executive Officer, Director
Next action: Open filing details

4 ARWR

ARROWHEAD PHARMACEUTICALS, INC.

Report period: 01 Jan 2022
Transactions: 1
Transaction value: $0
Filing time: 04 Jan 2022, 20:22
Role: Chief Executive Officer, Director
Next action: Open filing details

4 ARWR

ARROWHEAD PHARMACEUTICALS, INC.

Report period: 23 Dec 2021
Transactions: 2
Transaction value: +$61,273
Filing time: 23 Dec 2021, 20:52
Role: Chief Executive Officer, Director
Next action: Open filing details

4 ARWR

ARROWHEAD PHARMACEUTICALS, INC.

Report period: 15 Dec 2021
Transactions: 5
Transaction value: -$4,053,431
Filing time: 17 Dec 2021, 19:14
Role: Chief Executive Officer, Director
Next action: Open filing details

4 ARWR

ARROWHEAD PHARMACEUTICALS, INC.

Report period: 20 Oct 2021
Transactions: 3
Transaction value: -$4,274,982
Filing time: 22 Oct 2021, 17:58
Role: Chief Executive Officer, Director
Next action: Open filing details

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .